Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 4
2008 2
2009 2
2010 2
2011 1
2012 3
2013 5
2014 6
2015 8
2016 6
2017 4
2018 5
2019 4
2020 6
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
Secrier M, Li X, de Silva N, Eldridge MD, Contino G, Bornschein J, MacRae S, Grehan N, O'Donovan M, Miremadi A, Yang TP, Bower L, Chettouh H, Crawte J, Galeano-Dalmau N, Grabowska A, Saunders J, Underwood T, Waddell N, Barbour AP, Nutzinger B, Achilleos A, Edwards PA, Lynch AG, Tavaré S, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium. Secrier M, et al. Among authors: barbour ap. Nat Genet. 2016 Oct;48(10):1131-41. doi: 10.1038/ng.3659. Epub 2016 Sep 5. Nat Genet. 2016. PMID: 27595477 Free PMC article.
Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples.
Newell F, Patel K, Gartside M, Krause L, Brosda S, Aoude LG, Loffler KA, Bonazzi VF, Patch AM, Kazakoff SH, Holmes O, Xu Q, Wood S, Leonard C, Lampe G, Lord RV, Whiteman DC, Pearson JV, Nones K, Waddell N, Barbour AP. Newell F, et al. Among authors: barbour ap. BMC Med Genomics. 2019 Feb 4;12(1):31. doi: 10.1186/s12920-019-0476-9. BMC Med Genomics. 2019. PMID: 30717762 Free PMC article.
The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer.
Barbour AP, Samra JS, Haghighi KS, Donoghoe MW, Burge M, Harris MT, Chua YJ, Mitchell J, O'Rourke N, Chan H, Gebski VJ, Gananadha S, Croagh DG, Kench JG, Goldstein D; Australasian Gastro-Intestinal Trials Group (AGITG) GAP investigators. Barbour AP, et al. Ann Surg Oncol. 2020 Jul;27(7):2506-2515. doi: 10.1245/s10434-020-08205-2. Epub 2020 Jan 29. Ann Surg Oncol. 2020. PMID: 31997125 Clinical Trial.
Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus.
Visser E, Edholm D, Smithers BM, Thomson IG, Burmeister BH, Walpole ET, Gotley DC, Joubert WL, Atkinson V, Mai T, Thomas JM, Barbour AP. Visser E, et al. Among authors: barbour ap. J Surg Oncol. 2018 Jun;117(8):1687-1696. doi: 10.1002/jso.25089. Epub 2018 May 28. J Surg Oncol. 2018. PMID: 29806960
Controversies in the management of gastrointestinal stromal tumors.
Yip D, Zalcberg J, Ackland S, Barbour AP, Desai J, Fox S, Kotasek D, McArthur G, Smithers BM. Yip D, et al. Among authors: barbour ap. Asia Pac J Clin Oncol. 2014 Sep;10(3):216-27. doi: 10.1111/ajco.12187. Epub 2014 Mar 27. Asia Pac J Clin Oncol. 2014. PMID: 24673914 Review.
The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma.
van Hootegem SJM, Smithers BM, Gotley DC, Brosda S, Thomson IG, Thomas JM, Gartside M, van Lanschot JJB, Lagarde SM, Wijnhoven BPL, Barbour AP. van Hootegem SJM, et al. Among authors: barbour ap. Ann Surg Oncol. 2019 Aug;26(8):2375-2384. doi: 10.1245/s10434-019-07322-x. Epub 2019 Apr 2. Ann Surg Oncol. 2019. PMID: 30941657 Free PMC article.
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma.
Kryza T, Khan T, Puttick S, Li C, Sokolowski KA, Tse BW, Cuda T, Lyons N, Gough M, Yin J, Parkin A, Deryugina EI, Quigley JP, Law RHP, Whisstock JC, Riddell AD, Barbour AP, Wyld DK, Thomas PA, Rose S, Snell CE, Pajic M, He Y, Hooper JD. Kryza T, et al. Among authors: barbour ap. Theranostics. 2020 Mar 4;10(9):4116-4133. doi: 10.7150/thno.43589. eCollection 2020. Theranostics. 2020. PMID: 32226543 Free PMC article.
52 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page